|
|||||
![]() |
|
Bedding and comfort retailer Purple (NASDAQ:PRPL) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 12.6% year on year to $105.1 million. The company’s full-year revenue guidance of $475 million at the midpoint came in 1.7% above analysts’ estimates. Its non-GAAP loss of $0.11 per share was in line with analysts’ consensus estimates.
Is now the time to buy PRPL? Find out in our full research report (it’s free).
Purple’s second quarter results met Wall Street’s top- and bottom-line expectations, but the company’s 12.6% year-over-year revenue decline and negative market reaction reflected ongoing challenges. Management attributed performance to a mix of supply constraints in new product launches, evolving retail partnerships, and persistent tariff-related margin pressures. CEO Robert DeMartini noted that demand for the Rejuvenate 2.0 mattress exceeded supply, particularly in showrooms, and highlighted that the timing of inventory shipments to Mattress Firm and wholesale door exits from the previous year weighed on reported revenue. The company was candid about the temporary nature of these headwinds, emphasizing ongoing cost actions and operational improvements to support recovery.
Looking ahead, Purple’s guidance is anchored by the anticipated benefits from its expanded Mattress Firm partnership, new product launches, and margin recovery efforts. Management expects the rollout of Rejuvenate 2.0 and increased premium distribution to drive sequential revenue growth, while ongoing tariff mitigation and manufacturing efficiencies are projected to restore gross margins above 40% by year-end. CFO Todd Vogensen emphasized that improvements in both revenue and profitability are weighted toward the fourth quarter, as the company completes retail rollouts and addresses earlier supply chain bottlenecks. Purple is also focused on capital allocation priorities, aiming to invest in showroom growth and maintain a strong liquidity position as cash generation improves.
Management pointed to product launch momentum, supply chain adjustments, and evolving retail distribution as the main influences on second quarter performance and the company’s near-term outlook.
Purple’s outlook depends on the success of new product launches, expanded retail partnerships, and the effectiveness of ongoing margin recovery strategies amid a cautious consumer backdrop.
In the coming quarters, the StockStory team will focus on (1) the scale and effectiveness of the Mattress Firm rollout and other new retail partnerships, (2) the pace of gross margin recovery as tariff mitigation and cost-saving measures take hold, and (3) showroom profitability improvements alongside renewed e-commerce engagement. Further progress on distribution with large national retailers like Costco and Walmart will also serve as important indicators of Purple’s execution and brand traction.
Purple currently trades at $0.80, down from $0.85 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Aug-12 | |
Aug-12 | |
Aug-12 | |
Jul-30 | |
Jul-29 | |
Jul-29 | |
Jul-29 | |
Jul-29 | |
Jul-28 | |
Jul-27 | |
Jul-21 | |
Jul-17 | |
Jul-17 | |
Jun-29 | |
Jun-27 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite